Characteristics of tumor cell lines derived from DTG mice. (A) Flow cytometry evaluating CD19/CD5, CD19/sIgM, and CD19/CD23. (B) Semiquantitative RT-PCR evaluating cyclin D1, IL-14α, and c-Myc, as described in “Patients, materials, and methods.”